ARTICLE | Clinical News
Bone Medical preclinical data
February 4, 2008 8:00 AM UTC
In vitro, BN006 produced dose-dependent inhibition of interleukin-6 (IL-6) secretion and down-regulated the secretion of tumor necrosis factor (TNF) by macrophage-type cells. The compound is a TNF r...